Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombus: An Updated Meta-Analysis of Cohort Studies and Randomized Controlled Trials

Left ventricular thrombi (LVTs) increase the risk of stroke, systemic embolism, and subsequent death. Current guidelines recommend vitamin K antagonists (VKAs) as first-line treatment for LVT. Direct oral anticoagulants (DOACs) are increasingly used as alternatives to warfarin for the treatment of L...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yanming, Zhu, Mei, Wang, Kai, Xu, Qiang, Ma, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162267/
https://www.ncbi.nlm.nih.gov/pubmed/35383658
http://dx.doi.org/10.1097/FJC.0000000000001270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162267/
https://www.ncbi.nlm.nih.gov/pubmed/35383658
http://dx.doi.org/10.1097/FJC.0000000000001270

Ejemplares similares